Meng Yu

5.6k total citations · 1 hit paper
100 papers, 5.0k citations indexed

About

Meng Yu is a scholar working on Biomedical Engineering, Molecular Biology and Materials Chemistry. According to data from OpenAlex, Meng Yu has authored 100 papers receiving a total of 5.0k indexed citations (citations by other indexed papers that have themselves been cited), including 54 papers in Biomedical Engineering, 31 papers in Molecular Biology and 28 papers in Materials Chemistry. Recurrent topics in Meng Yu's work include Nanoplatforms for cancer theranostics (41 papers), Nanoparticle-Based Drug Delivery (21 papers) and Advanced Nanomaterials in Catalysis (15 papers). Meng Yu is often cited by papers focused on Nanoplatforms for cancer theranostics (41 papers), Nanoparticle-Based Drug Delivery (21 papers) and Advanced Nanomaterials in Catalysis (15 papers). Meng Yu collaborates with scholars based in China, United States and Japan. Meng Yu's co-authors include Changchun Wang, Fengping Tan, Jia Guo, Zhiqiang Yu, Wanfu Ma, Fang Guo, Yuting Zhang, Nan Li, Haojie Lu and Jinping Wang and has published in prestigious journals such as Nano Letters, ACS Nano and Biomaterials.

In The Last Decade

Meng Yu

94 papers receiving 4.9k citations

Hit Papers

An acid-responsive MOF nanomedicine for augmented anti-tu... 2023 2026 2024 2025 2023 25 50 75

Peers

Meng Yu
Comparison fields: 5 of 119
  • Biomedical Engineering 2.6k
  • Molecular Biology 1.6k
  • Materials Chemistry 1.6k
  • Biomaterials 1.2k
  • Pulmonary and Respiratory Medicine 512
Replace Jun Feng with:
Jun Feng China
Xiangdong Xue China
Yongdoo Choi South Korea
Shubin Jin China
Wei‐Hai Chen China
Yong Hu China
Jianbin Tang China
Zhiai Xu China
Xinjian Yang China
Jun Feng China View profile →
Citations per field, relative to Meng Yu
Meng Yu · 1×
Citations per year, relative to Meng Yu
Meng Yu · 1×

Countries citing papers authored by Meng Yu

Since Specialization
Citations

This map shows the geographic impact of Meng Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Meng Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Meng Yu more than expected).

Fields of papers citing papers by Meng Yu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Meng Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Meng Yu. The network helps show where Meng Yu may publish in the future.

Co-authorship network of co-authors of Meng Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Meng Yu. A scholar is included among the top collaborators of Meng Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Meng Yu. Meng Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Work Indexed citations
1 12
2 3
3 1
4 1
5 9
6 8
7
An acid-responsive MOF nanomedicine for augmented anti-tumor immunotherapy via a metal ion interference-mediated pyroptotic pathway breakdown →
99
8 9
9 6
10 29
11 21
12 62
13 217
14 87
15 8
16 115
17 52
18 31
19
Inhibition of EZH2 reverses chemotherapeutic drug TMZ chemosensitivity in glioblastoma.
62
20 41

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026